Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
NVST
Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know StockStory - Fri Apr 17, 3:16PM CDT

Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen Stocks Trade Up, What You Need To Know

RGEN : 131.21 (+3.24%)
BAX : 18.71 (+3.14%)
CRL : 183.88 (+3.92%)
NVST : 27.84 (+3.34%)
SGRY : 14.00 (+4.24%)
Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call Business Wire - Thu Apr 16, 7:00AM CDT

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2026 financial results on Thursday, May 7 th , before the market opens. A conference call has been scheduled...

CRL : 183.88 (+3.92%)
Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association Business Wire - Thu Apr 9, 3:30PM CDT

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with the American Heart Association, the world’s leading nonprofit organization focused on heart and brain health,...

CRL : 183.88 (+3.92%)
GH
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know StockStory - Mon Apr 6, 2:30PM CDT

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

FTRE : 10.38 (+2.87%)
GH : 90.36 (+5.44%)
OGN : 9.76 (+4.61%)
CRL : 183.88 (+3.92%)
QDEL : 12.71 (+0.20%)
NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX PR Newswire - Mon Apr 6, 7:55AM CDT

NYSE issues a pre-market daily advisory direct from the trading floor.

ICE : 161.24 (-1.53%)
CRL : 183.88 (+3.92%)
VNT
1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds StockStory - Wed Apr 1, 11:35PM CDT

1 Cash-Producing Stock with Exciting Potential and 2 Facing Headwinds

HP : 33.64 (-3.72%)
CRL : 183.88 (+3.92%)
VNT : 37.30 (+2.28%)
RDNT
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know StockStory - Fri Mar 27, 12:56PM CDT

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

ILMN : 134.50 (+1.34%)
EVH : 2.84 (-5.02%)
RGEN : 131.21 (+3.24%)
CRL : 183.88 (+3.92%)
RDNT : 60.39 (+0.50%)
MU
1 Value Stock on Our Buy List and 2 We Turn Down StockStory - Thu Mar 26, 11:35PM CDT

1 Value Stock on Our Buy List and 2 We Turn Down

MU : 455.07 (-0.47%)
JLL : 346.43 (+3.64%)
CRL : 183.88 (+3.92%)
Charles River Laboratories International Inc_ chart and logo-by IgorGolovniov via Shutterstock
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector? Barchart - Mon Mar 23, 6:32PM CDT

While Charles River Laboratories has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

XLV : 148.80 (+1.49%)
CRL : 183.88 (+3.92%)
IQV : 176.46 (+2.62%)
CRL
3 Reasons CRL is Risky and 1 Stock to Buy Instead StockStory - Wed Mar 11, 11:05PM CDT

3 Reasons CRL is Risky and 1 Stock to Buy Instead

CRL : 183.88 (+3.92%)

Barchart Exclusives

Alibaba Just Launched New AI Models for Video Games. Does That Make BABA Stock a Buy? Barchart - 15 minutes ago
Alibaba’s new Happy Oyster AI model can be used to develop video games. Does this make BABA stock a buy now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.